about
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeBlood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live trackingA simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrierSusceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activityModeling of PET data in CNS drug discovery and development.Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis dataDeveloping Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR ModelingCharacterization of a novel brain barrier ex vivo insect-based P-glycoprotein screening model.TRPA1: a transducer and amplifier of pain and inflammation.Effect of transporter inhibition on the distribution of cefadroxil in rat brainPhysicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent Crone-Renkin equation.The fate of ultrafast degrading polymeric implants in the brain.Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in HumansValidation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport.Kinetics of functionalised carbon nanotube distribution in mouse brain after systemic injection: Spatial to ultra-structural analysesPharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects.Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition.The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study.Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approachLevels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats.Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.Role of membrane transporters in the safety profile of drugs.Assessing brain free fraction in early drug discovery.Development of a physiologically-based pharmacokinetic model of the rat central nervous system.Drug delivery to the CNS and polymeric nanoparticulate carriers.Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity.Shuttle-mediated drug delivery to the brain.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling.Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats.Improving the prediction of drug disposition in the brain.Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.Utility of CSF in translational neuroscience.
P2860
Q26753140-7058A4E5-803A-4E5F-993E-087DBE1D32C3Q26850858-84F46B99-7B93-460B-977A-70B9795494D6Q28067855-CCA34786-C5D7-4421-9FFA-E77D8019F113Q28535720-0AF04CDB-8023-445F-B4A1-C6033CF09C9BQ30532529-D69303AC-FCEF-42E9-A68C-EF577F7E4F45Q30623699-AEBB31B8-C868-47DE-9C8C-3F491C411356Q30651426-4DED7533-AD68-45A3-AFAE-36A317FE1F5FQ30700231-D743101B-7DBC-4069-911B-1C0880085982Q30929535-56BE3AA7-2FF7-40F1-8D0F-204ACD34F663Q34292573-F969FC4D-76BE-462A-BA7B-A003660177A0Q34376133-5C0ABD71-F36F-4319-99D6-6AFEC7CAC97BQ34544043-77F653B1-6849-4F61-A11B-2B7DC94844F9Q34556508-8C8EBCF4-BE22-4A2F-A7E8-0F5947238E88Q34789397-C0906CDB-8C23-4627-A482-2BB555918F3DQ35028187-76D36D95-E64D-44A7-9D93-E342A44B791FQ35529165-2BBE6D83-B691-4A6F-AC88-16B551873BD3Q35560848-25A07901-4C80-4E50-B0DF-87EFBE6A08E7Q36587432-EC1B398C-B622-4A12-ADF4-BAA09101B1DAQ36600202-33672C5C-9744-4035-BAAB-F0046C1B1CD6Q36638627-90C7A48D-4A6F-457B-9E89-441BE4DF5E8CQ36697929-32711197-071F-4FEB-AC79-B74456D04976Q36925745-1CF0966B-1371-4EF9-B66F-69D40F3178C2Q37185659-2129243F-E683-4761-B355-03CD5F871ADCQ37207750-FD659E05-52F8-4E34-AD19-52B2E02E9080Q37219079-CE350E6A-064A-4C25-BA27-75FE00ADCF49Q37251993-BAB6977E-668B-4523-A178-E4ABC518BB27Q37311185-F85EC3A0-5851-422B-8546-C5735A0E8638Q37355679-532901E7-F985-47AE-B75E-FC54C07C2245Q37575644-BBF7E8BA-3EA8-4D43-9A42-6F2E2248C0F8Q37681555-BAAFFE73-776C-47FF-807B-2C2467F26EAEQ37689854-9991F69B-6EC8-45A0-978A-8EDD7261AB1FQ37856301-309A01D8-D893-4F0E-8A2B-2F5B31699D0DQ37872394-E1028459-E641-4ADF-B81D-F042A1667E65Q37896550-EE47010E-06FD-4567-A4B2-F16589AFAF79Q37995554-DDE429A5-45E6-4ED2-80F3-00E27D6EB50AQ37998107-A56F100F-E327-49F8-B83B-568D1A4DAC90Q38010342-4AD13470-D3ED-44C0-9357-409F24F4AE53Q38072077-1C24EF67-4439-493B-8F8D-9146137BD314Q38075010-8510AF7F-EFC4-4E28-9195-A85F3694F46CQ38080762-458FBDA2-5BAA-4016-B2D8-798E87428E50
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
On the rate and extent of drug delivery to the brain.
@en
On the rate and extent of drug delivery to the brain.
@nl
type
label
On the rate and extent of drug delivery to the brain.
@en
On the rate and extent of drug delivery to the brain.
@nl
prefLabel
On the rate and extent of drug delivery to the brain.
@en
On the rate and extent of drug delivery to the brain.
@nl
P2093
P2860
P1476
On the rate and extent of drug delivery to the brain
@en
P2093
Anubha Gupta
Margareta Hammarlund-Udenaes
Markus Fridén
P2860
P304
P356
10.1007/S11095-007-9502-2
P577
2007-12-05T00:00:00Z